NEW YORK (GenomeWeb) – Synthego said today that Thermo Fisher Scientific will market and sell its synthetic guide RNA products under a Thermo Fisher brand.

Synthego will manufacture synthetic guide RNAs for Thermo Fisher, including a synthetic crRNA:tracrRNA, a synthetic single guide RNA, and a chemically modified sgRNA. Thermo Fisher will sell these products, which may differ from Synthego's own products in configuration and design, under the Invitrogen TrueGuide brand.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.